Functionalized Anti-Infective Surfaces for Medical Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling infections, particularly in medical devices and public surfaces, are inadequate as they often require frequent application and can be harmful to mammalian tissue, and existing solutions do not effectively prevent bacterial colonization and biofilm formation on implants and surfaces.
Innovation Solution
Functionalizing various material surfaces with an active region to bind anti-infective agents, such as quaternary ammonium compounds and silver, using methods like self-assembled monolayers and oxide adhesion layers, to create durable and effective anti-infective surfaces that can be applied universally, including in medical devices and public areas.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If topical disinfectants and antiseptics are applied to surfaces, then infection control is achieved, but frequent reapplication is needed and harmful effects on mammalian tissue occur
Solution Approach 1:
The patent applies preliminary action by pre-coating medical device surfaces with functionalized layers containing anti-infective agents before implantation. The surfaces are prepared in advance with oxide adhesion layers and self-assembled monolayers that bind antimicrobial compounds, creating proactive protection rather than requiring post-implantation application of harmful disinfectants.
Solution Approach 2:
The patent uses intermediary layers (oxide adhesion layers and self-assembled monolayers) as mediators between the medical device surface and anti-infective agents. These intermediary layers provide binding sites for antimicrobial compounds, enabling effective infection control without direct contact between harmful disinfectants and mammalian tissue.
2Reliability
If antibiotics are administered to stop infection, then bacterial growth is inhibited, but treatment is not always effective and aggressive therapies are required
Solution Approach 1:
The patent applies preliminary action by pre-coating medical device surfaces with functionalized layers containing anti-infective agents before implantation. The surfaces are prepared in advance with oxide adhesion layers and self-assembled monolayers that bind antimicrobial compounds, creating proactive protection rather than requiring post-implantation application of harmful disinfectants.
Solution Approach 2:
The patent enables self-service by creating medical devices with surfaces that autonomously resist bacterial colonization. The functionalized surfaces continuously release or present anti-infective agents, providing self-protection against infection without requiring external administration of antibiotics or aggressive therapeutic interventions.
3Reliability
If medical implants are used, then surgical outcomes are improved, but bacterial colonization and biofilm formation occur on implant surfaces
Solution Approach 1:
The patent applies preliminary anti-action by pre-treating implant surfaces with functionalized layers containing anti-infective agents before the bacteria can colonize. The oxide adhesion layers and self-assembled monolayers are applied in advance to create surfaces that actively prevent bacterial adhesion and biofilm formation, countering the harmful effect before it occurs.
Solution Approach 2:
The patent enables self-service by creating medical devices with surfaces that autonomously resist bacterial colonization. The functionalized surfaces continuously release or present anti-infective agents, providing self-protection against infection without requiring external administration of antibiotics or aggressive therapeutic interventions.
4Reliability
If external fixation devices are used, then bone healing is facilitated, but pin-tract infection risk increases
Solution Approach 1:
The patent applies preliminary action by pre-coating medical device surfaces with functionalized layers containing anti-infective agents before implantation. The surfaces are prepared in advance with oxide adhesion layers and self-assembled monolayers that bind antimicrobial compounds, creating proactive protection rather than requiring post-implantation application of harmful disinfectants.
Solution Approach 2:
The patent enables self-service by creating medical devices with surfaces that autonomously resist bacterial colonization. The functionalized surfaces continuously release or present anti-infective agents, providing self-protection against infection without requiring external administration of antibiotics or aggressive therapeutic interventions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The anti-infective surfaces continuously and proactively kill bacteria, reducing the incidence of infections, minimizing biofilm formation, and providing clinical benefits by eliminating the need for frequent disinfection and reducing the risk of complications associated with implant-related infections.
Implementation Method 1
an activated, or functionalized, layer that is bonded or otherwise disposed on the surface of a substrate... This functionalized layer allows the substrate to react with and to bind to the organic or metallic material
Implementation Method 2
using methods like self-assembled monolayers and oxide adhesion layers
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Devices are provided which are functionalized to include surface regions having anti- infective agents. Methods are provided for functionalizing various material surfaces to include active surface regions for binding anti-infective agents. Methods are provided by which anti- infective moieties or agents are bonded to functionalized surfaces.